Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia

MeSH terms

• Anticholesteremic Agents / adverse effects
• Anticholesteremic Agents / therapeutic use*
• Azetidines / adverse effects
• Azetidines / therapeutic use*
• Biomarkers / blood
• C-Reactive Protein / metabolism
• Carotid Artery Diseases / blood
• Carotid Artery Diseases / genetics
• Carotid Artery Diseases / prevention & control*
• Cholesterol, LDL / blood
• Creatinine / blood
• Drug Combinations
• Ezetimibe, Simvastatin Drug Combination
• Humans
• Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
• Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
• Hyperlipoproteinemia Type II / blood
• Hyperlipoproteinemia Type II / complications
• Hyperlipoproteinemia Type II / drug therapy*
• Hyperlipoproteinemia Type II / genetics
• Simvastatin / adverse effects
• Simvastatin / therapeutic use*
• Time Factors
• Treatment Outcome
• Triglycerides / blood